Enzo Boeri

3.2k total citations
74 papers, 1.7k citations indexed

About

Enzo Boeri is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Enzo Boeri has authored 74 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Infectious Diseases, 38 papers in Virology and 14 papers in Molecular Biology. Recurrent topics in Enzo Boeri's work include HIV Research and Treatment (38 papers), HIV/AIDS drug development and treatment (37 papers) and HIV/AIDS Research and Interventions (22 papers). Enzo Boeri is often cited by papers focused on HIV Research and Treatment (38 papers), HIV/AIDS drug development and treatment (37 papers) and HIV/AIDS Research and Interventions (22 papers). Enzo Boeri collaborates with scholars based in Italy, United States and France. Enzo Boeri's co-authors include Adriano Lazzarin, Genoveffa Franchini, Antoine Gessain, Antonella Castagna, Massimo Clementi, Nicola Gianotti, Roger Bonnichsen, Nils Andreas Sörensen, Jörgine Stene Sörensen and Richard Yanagihara and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Virology and Biochemical and Biophysical Research Communications.

In The Last Decade

Enzo Boeri

72 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Enzo Boeri Italy	23	639	629	453	380	370	74	1.7k
Yanru Feng China	23	599 0.9×	423 0.7×	357 0.8×	506 1.3×	141 0.4×	96	2.3k
Jochen Bodem Germany	24	632 1.0×	674 1.1×	149 0.3×	739 1.9×	103 0.3×	68	2.2k
Robert E. Palermo United States	29	512 0.8×	502 0.8×	653 1.4×	767 2.0×	60 0.2×	57	2.7k
S. Jönsson Iceland	24	317 0.5×	487 0.8×	194 0.4×	718 1.9×	70 0.2×	45	1.8k
Kui Zhao China	21	324 0.5×	174 0.3×	118 0.3×	411 1.1×	66 0.2×	102	1.6k
S.J. Crennell United Kingdom	18	183 0.3×	98 0.2×	195 0.4×	962 2.5×	49 0.1×	45	1.9k
Isabelle Pelletier France	26	475 0.7×	37 0.1×	683 1.5×	923 2.4×	101 0.3×	58	2.1k
Ming‐Chu Hsu United States	19	309 0.5×	204 0.3×	184 0.4×	838 2.2×	32 0.1×	36	1.8k
Han G. Huisman Netherlands	18	947 1.5×	1.4k 2.3×	699 1.5×	612 1.6×	53 0.1×	35	2.6k
Guy D. Diana United States	18	391 0.6×	44 0.1×	128 0.3×	472 1.2×	181 0.5×	39	1.6k

Countries citing papers authored by Enzo Boeri

Since Specialization

Citations

This map shows the geographic impact of Enzo Boeri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enzo Boeri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enzo Boeri more than expected).

Fields of papers citing papers by Enzo Boeri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Enzo Boeri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enzo Boeri. The network helps show where Enzo Boeri may publish in the future.

Co-authorship network of co-authors of Enzo Boeri

This figure shows the co-authorship network connecting the top 25 collaborators of Enzo Boeri. A scholar is included among the top collaborators of Enzo Boeri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Enzo Boeri. Enzo Boeri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nozza, Silvia, Laura Galli, Valentina Svicher, et al.. (2016). 48 week outcomes of maraviroc-containing regimens following the genotypic or Trofile assay in HIV-1 failing subjects: the OSCAR Study.. PubMed. 39(3). 192–196.

Cavarelli, Mariangela, Alba Bigoloni, Monica Tolazzi, et al.. (2014). Complexity and Dynamics of HIV-1 Chemokine Receptor Usage in a Multidrug-Resistant Adolescent. AIDS Research and Human Retroviruses. 30(12). 1243–1250. 3 indexed citations

Canducci, Filippo, Elisa Rita Ceresola, Enzo Boeri, et al.. (2011). Cross-resistance Profile of the Novel Integrase Inhibitor Dolutegravir (S/GSK1349572) Using Clonal Viral Variants Selected in Patients Failing Raltegravir. The Journal of Infectious Diseases. 204(11). 1811–1815. 83 indexed citations

Canducci, Filippo, Beatrice Barda, Elisa Rita Ceresola, et al.. (2010). Evolution patterns of raltegravir-resistant mutations after integrase inhibitor interruption. Clinical Microbiology and Infection. 17(6). 928–934. 22 indexed citations

Rusconi, Stefano, Fulvio Adorni, Paola Vitiello, et al.. (2010). Prevalence of mutations and determinants of genotypic resistance to etravirine (TMC125) in a large Italian resistance database (ARCA)^*†. HIV Medicine. 11(8). 530–534. 7 indexed citations

Canducci, Filippo, Michela Sampaolo, Maria Chiara Marinozzi, et al.. (2009). Dynamic patterns of human immunodeficiency virus type 1 integrase gene evolution in patients failing raltegravir-based salvage therapies. AIDS. 23(4). 455–460. 65 indexed citations

Hasson, Hamid, Barbara Mantelli, Priscilla Biswas, et al.. (2007). Favorable outcome of ex‐vivo purging of monocytes after the reintroduction of treatment after interruption in patients infected with multidrug resistant HIV‐1. Journal of Medical Virology. 79(11). 1640–1649. 5 indexed citations

Gianotti, Nicola, Maria Cecilia Rossi, Elisabetta Chiesa, et al.. (2006). Comparison of a Rule-Based Algorithm with a Phenotype-Based Algorithm for the Interpretation of HIV Genotypes in Guiding Salvage Regimens in HIV-Infected Patients by a Randomized Clinical Trial: The Mutations and Salvage Study. Clinical Infectious Diseases. 42(10). 1470–1480. 8 indexed citations

Gianotti, Nicola, Laura Galli, Enzo Boeri, et al.. (2006). The 118I Reverse Transcriptase Mutation Is the Only Independent Genotypic Predictor of Virologic Failure to a Stavudine-Containing Salvage Therapy in HIV-1-Infected Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes. 41(4). 447–452. 7 indexed citations

10.

Gianotti, Nicola, Elena Seminari, Adriano Lazzarin, et al.. (2005). Redistribution of Human Immunodeficiency Virus Type 1 Variants Resistant to Protease Inhibitors after a Protease Inhibitor-Sparing Regimen. AIDS Research and Human Retroviruses. 21(6). 545–554. 2 indexed citations

11.

Hasson, Hamid, Nicola Gianotti, Anna Danise, et al.. (2004). Resistance to amprenavir before and after treatment with lopinavir/ritonavir in highly protease inhibitor-experienced HIV patients. AIDS. 18(1). 121–123. 5 indexed citations

12.

Gianotti, Nicola, et al.. (2004). In vivo dynamics of the 103N mutation following the withdrawal of non-nucleoside reverse transcriptase inhibitors in HIV-infected patients: preliminary results.. PubMed. 27(2 Suppl 1). 111–7. 5 indexed citations

13.

Boeri, Enzo, Nicola Gianotti, Filippo Canducci, et al.. (2003). Evolutionary Characteristics of HIV Type 1 Variants Resistant to Protease Inhibitors in the Absence of Drug-Selective Pressure. AIDS Research and Human Retroviruses. 19(12). 1151–1153. 16 indexed citations

14.

Uberti‐Foppa, Caterina, Anna De Bona, Giulia Morsica, et al.. (2003). Pretreatment of Chronic Active Hepatitis C in Patients Coinfected With HIV and Hepatitis C Virus Reduces the Hepatotoxicity Associated With Subsequent Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 33(2). 146–152. 33 indexed citations

15.

Brambilla, Anna Maria, Antonella Castagna, Hamid Hasson, et al.. (2001). Relation Between CD4 Cell Counts and HIV RNA Levels at Onset of Opportunistic Infections. JAIDS Journal of Acquired Immune Deficiency Syndromes. 27(1). 44–48. 12 indexed citations

16.

Cinque, Paola, Arabella Bestetti, Sara Racca, et al.. (2001). Effect of Genotypic Resistance on the Virological Response to Highly Active Antiretroviral Therapy in Cerebrospinal Fluid. AIDS Research and Human Retroviruses. 17(5). 377–383. 36 indexed citations

17.

Safai, Bijan, Junling Huang, Enzo Boeri, et al.. (1996). Prevalence of HTLV Type I Infection in Iran: A Serological and Genetic Study. AIDS Research and Human Retroviruses. 12(12). 1185–1190. 50 indexed citations

18.

Boeri, Enzo, et al.. (1995). Analysis of HTLV-I Env Gene Sequence from an Italian Polytransfused Patient: Evidence for a Zairian HTLV-I in Sicily. AIDS Research and Human Retroviruses. 11(5). 649–651. 5 indexed citations

19.

Gessain, Antoine, Igor J. Koralnik, Jake Fullen, et al.. (1994). Phylogenetic Study of Ten New HTLV-I Strains from the Americas. AIDS Research and Human Retroviruses. 10(1). 103–106. 21 indexed citations

20.

Boeri, Enzo, et al.. (1993). Short Communication: Qualitative Changes in the Human T-Cell Leukemia/ Lymphotropic Virus Type I env Gene Sequence in the Spastic Versus Nonspastic Tropical Paraparesis Are Not Correlated with Disease Specificity. AIDS Research and Human Retroviruses. 9(1). 1–5. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact